Detail akcie Cooper Co Rg online

Business Summary: The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Financial Summary: BRIEF: For the fiscal year ended 31 October 2025, Cooper Companies Inc revenues increased 5% to $4.09B. Net income decreased 4% to $374.9M. Revenues reflect CooperVision segment increase of 5% to $2.74B, CooperSurgical segment increase of 5% to $1.35B, Europe segment increase of 8% to $1.25B, United States segment increase of 4% to $2.05B, Rest of the World segment increase of 1% to $785.2M.